I

Intercept Pharmaceuticals

458 employees

Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Pharmaceutical
Biotechnology
Rare Diseases
Health Care
Innovation
Non-viral Liver Diseases

Date founded

2002

Funding rounds raised

Total raised

$41M

from 4 investors over 4 rounds

I

Intercept Pharmaceuticals raised $30M on August 10, 2012

Investors: Aisling Capital and OrbiMed Advisors

I

Intercept Pharmaceuticals raised $41M on May 16, 2006

Investors: Balyasny Asset Management L.P.

I

Intercept Pharmaceuticals raised $1.3M on May 4, 2005

Investors: Rodman & Renshaw

FAQ